stockrow
Friday 6 November 2026
Export CC’s income statement to Excel — free account
The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
12.82
0.97
−7.03%
Follow CC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 4 | 4 | 6 |
| (90.40%) | (99.50%) | (303.66%) | (67.54%) | ||
| (5.00%) | (5.40%) | (3.96%) | (2.07%) | ||
ROIC |
(1.08%) | (1.50%) | (2.22%) | 0.44% | |
Return on Tangible Assets |
(8.47%) | (9.08%) | (6.81%) | (3.46%) | |
Average Days of Receivables |
42.67 | 47.59 | 57.11 | 57.61 | |
Free Cash Flow per Share |
0.34 | 1.02 | 1.44 | 1.35 | |
Free Cash Flow |
51.00 | 154.00 | 218.00 | 204.00 | |
Capital Expenditures |
(213.00) | (178.00) | (179.00) | (196.00) | |
| Other line items | |||||
Cash ROIC |
1.01% | 3.13% | 4.85% | 4.31% | |
Accounts Receivable Turnover |
8.02 | 7.20 | 6.21 | 6.25 | |
Accounts Payable Turnover |
4.65 | 5.21 | 5.01 | 4.88 | |
Inventory Turnover |
3.24 | 3.20 | 3.26 | 3.28 | |
Average Days of Payables |
70.98 | 65.79 | 69.64 | 73.25 | |
Days of Inventory on Hand |
116.73 | 113.42 | 107.92 | 108.59 | |
Tax Rate |
0.39 | 0.37 | 4.87 | (2.42) | |
Research and Development Expense of Revenue |
1.86% | 1.84% | 1.83% | 1.78% | |
Selling, General and Administrative Expense of Revenue |
13.76% | 14.14% | 14.97% | 12.56% | |
Share Based Compensation of Revenue |
0.36% | 0.40% | 0.40% | 0.38% | |
Interest Coverage |
(0.24) | (0.33) | (0.41) | 0.08 | |
Operating CF/Net income |
(0.71) | (0.84) | (1.37) | (2.60) | |
Depreciation/Fixed assets |
0.11 | 0.11 | 0.11 | 0.11 | |
Capex/Depreciation |
(0.61) | (0.52) | (0.54) | (0.59) | |
Revenue per Share |
38.66 | 38.61 | 38.33 | 38.60 | |
Operating CF per Share |
1.76 | 2.20 | 2.63 | 2.64 | |
Capex per Share |
(1.42) | (1.18) | (1.18) | (1.30) | |
Capex to Sales |
0.04 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026